These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 27570419)

  • 1. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Other Gastric and Duodenal Neuroendocrine Tumors.
    Laird AM; Libutti SK
    Surg Oncol Clin N Am; 2020 Apr; 29(2):253-266. PubMed ID: 32151359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric neuroendocrine tumors].
    Alekberzade AV; Krylov NN; Lipnitskiy EM; Shakhbazov RO; Azari F
    Khirurgiia (Mosk); 2019; (12):111-120. PubMed ID: 31825351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum].
    Shimizu N; Kaminishi M
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric and duodenal neuroendocrine tumours.
    O'Toole D; Delle Fave G; Jensen RT
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
    McCarthy DM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Tumors of the Stomach.
    Corey B; Chen H
    Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
    Akerström G
    World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
    Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
    Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.
    Exarchou K; Howes N; Pritchard DM
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1247-1267. PubMed ID: 32390152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Duodenal neuroendocrine tumors].
    Alekberzade AV; Krylov NN; Garmanova TN; Shahbazov R; Azari F; Zuykova KS; Litovchenko ED
    Khirurgiia (Mosk); 2019; (7):87-95. PubMed ID: 31355821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of gastric neuroendocrine tumours.
    Plöckinger U
    Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
    Lee HE; Mounajjed T; Erickson LA; Wu TT
    Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
    Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
    Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric neuroendocrine tumors.
    Delle Fave G; Capurso G; Annibale B; Panzuto F
    Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.
    Hoffmann KM; Furukawa M; Jensen RT
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):675-97. PubMed ID: 16253893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.
    Delle Fave G; O'Toole D; Sundin A; Taal B; Ferolla P; Ramage JK; Ferone D; Ito T; Weber W; Zheng-Pei Z; De Herder WW; Pascher A; Ruszniewski P;
    Neuroendocrinology; 2016; 103(2):119-24. PubMed ID: 26784901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.